Trials / Completed
CompletedNCT00724919
A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli
Association of Antibiotic Utilization Measures and Control of Extended-Spectrum β-Lactamases (ESBLs) (A Post-Intervention Surveillance Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 256 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the acquisition rate of ESBL producing E. coli or K. pneumoniae, post- intervention in the selected medical centres
Detailed description
This is post-interventional study to follow the acquisition rate of ESBP producing E. coli or K. pneumoniae at the sites involved in a previous interventional study.
Conditions
Timeline
- Start date
- 2003-12-01
- Primary completion
- 2004-04-01
- Completion
- 2004-04-01
- First posted
- 2008-07-30
- Last updated
- 2008-08-11
Locations
2 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00724919. Inclusion in this directory is not an endorsement.